Tuesday 13 May, 2025 10:13 AM
Site map | Locate Us | Login
   Raymond slides as Q4 PAT slumps 40% YoY to Rs 137 crore    Healthcare shares gain    Jindal Poly Films' subsidiary to undertake Rs 700 crore capex for setting up new film lines    DCX Systems edges higher after bagging export order from various international clients    Morepen Labs slides as Q4 PAT decline 29% YoY to Rs 20 crore    Happiest Minds Technologies Ltd Falls 1.5%    Sun Pharmaceutical Industries Ltd Spurts 2.83%, BSE Healthcare index Rises 1.26%    Allied Blenders' board to mull fund-raising plan on 15 May    Newgen Software Tech gains after arm secures $1.63 million contract    Man Industries hits the roof after PAT rises nearly 3x YoY to Rs 68 crore in Q4    Piramal Pharma gains after receiving EIR for Turbhe facility from USFDA    Wanbury spurts after Tanuku facility clears ANVISA inspection with zero observations    K P R Mill Ltd leads losers in 'A' group    Bajaj Electricals soars after strong Q4 performance    Dr Reddys Lab jumps after Q4 PAT rises 22% YoY 
Saravan Stocks
       
Hot Pursuit
Scrips, which has significant changes during the market hours.
Lupin gets USFDA nod for schizophrenia drug
21-Mar-23   15:36 Hrs IST

The approved ANDA is generic equivalent to Rexulti tablets of Otsuka Pharmaceutical Company. The drug is used to treat certain mental/mood disorders such as schizophrenia, depression. This product will be manufactured at company's Pithampur facility in India.

Brexpiprazole tablets, 0.25 mg, 0.5 mg, 1 mg, 2 mg, 3 mg, and 4 mg, (RLD Rexulti) had estimated annual sales of $1,575 million in the U.S. (IQVIA MAT December 2022).

Meanwhile, the company announced that its alliance partner, Caplin Steriles received final approval from the USFDA to market Rocuronium Bromide Injection and Thiamine Hydrochloride Injection USP.

Mumbai-based Lupin is a transnational pharmaceutical company. It develops and commercializes a wide range of branded and generic formulations, biotechnology products, and APIs in over 100 markets in the U.S., India, South Africa, and across the Asia Pacific (APAC), Latin America (LATAM), Europe, and Middle East regions.

The company reported 71.9% drop in net profit to Rs 153.5 crore despite of 3.8% rise in net sales to Rs to Rs 4,244.6 crore in Q3 FY23 over Q3 FY22.

The scrip rose 0.26% to Rs 647.90 on the BSE.

Powered by Capital Market - Live News

   Attention Investors : Prevent Unauthorized Transactions in your demat account --> Update your Mobile Number with your Depository Participant. Receive alerts on your Registered Mobile for all debit and other important transactions in your demat account directly from CDSL on the same day........issued in the interest of investors.
   Attention Investors : Prevent unauthorised transactions in your account Update your mobile numbers/email IDs with your stock brokers / Depository Participant. Receive information of your transactions directly from Exchange / Depositories on your mobile / email at the end of the day .... Issued in the interest of Investors.
   Attention Investors : KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.
   Attention Investors : No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."
Email ID: info@ssplwealth.com       Customers grievances : grievances@ssplwealth.com     Compliance officer : Mr.R Udayakumar , compliance@ssplwealth.com,  Mobile No: 7305522205
Hit Count : 40814296
SEBI Regn.Nos : NSE/BSE-INZ000192638 | CDSL : IN-DP-262-2016
Member IDs : NSE : 11221 | BSE : 6292 | CDSL : 12045000 | MCX : 56990 | AMFI Regn.No : 2662
Designed , Developed & Content provided by CMOTS INFOTECH.(ISO 9001:2015 certified) © Copyright 2011 All Rights Reserved. SSPL WEALTH Pvt. Ltd